Is A Rise Imminent For Intellia Therapeutics Stock After 30% Fall In A Month?
- Tuesday, March 8, 2022, 7:13
- Market
- Add a comment
The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31% fall in a month while it is down 34% over the last week. This can be attributed to the U.S. Patents & Trademark Office ruling invalidating a key…
About the Author
admin123 has written 23398 stories on this site.
